Evidence map›Paper›PMID 35631313›Full record

ArticleNutrients2022

The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

Alejandra Abascal-Saiz, Marta Duque-Alcorta, Victoria Fioravantti, Eugenia Antolín, Eva Fuente-Luelmo, María Haro, María P Ramos-Álvarez, Germán Perdomo, José L Bartha

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Alejandra Abascal-SaizDepartment of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain.ORCID 0000-0001-9584-3921
Marta Duque-AlcortaDepartment of Clinical Chemistry, La Paz University Hospital, 28046 Madrid, Spain.
Victoria FioravanttiDepartment of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesus, 28009 Madrid, Spain.
Eugenia AntolínDepartment of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain.
Eva Fuente-LuelmoDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, CEU-San Pablo University, 28668 Madrid, Spain.
María HaroDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, CEU-San Pablo University, 28668 Madrid, Spain.ORCID 0000-0002-7736-1096
María P Ramos-ÁlvarezDepartment of Biochemistry and Molecular Biology, Faculty of Pharmacy, CEU-San Pablo University, 28668 Madrid, Spain.ORCID 0000-0002-7727-7783
Germán PerdomoUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.ORCID 0000-0002-2301-0012
José L BarthaDepartment of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain.
Hospital Universitario La Paz · ESUniversidad San Pablo CEU · ESHospital Infantil Universitario Niño Jesús · ESUniversidad de Valladolid · ES

Funding

Instituto de Salud Carlos III PI12/01947
6 · The paper itself

Abstract

Antiangiogenic factors are currently used for the prediction of preeclampsia. The present study aimed to evaluate the relationship between antiangiogenic factors and lipid and carbohydrate metabolism in maternal plasma and placenta. We analyzed 56 pregnant women, 30 healthy and 26 with preeclampsia (including early and late onset). We compared antiangiogenic factors soluble Fms-like Tyrosine Kinase-1 (sfLt-1), placental growth factor (PlGF), and soluble endoglin (sEng)), lipid and carbohydrate metabolism in maternal plasma, and lipid metabolism in the placenta from assays of fatty acid oxidation, fatty acid esterification, and triglyceride levels in all groups. Antiangiogenic factors sFlt-1, sFlt-1/PlGF ratio, and sEng showed a positive correlation with triglyceride, free fatty acid, and C-peptide maternal serum levels. However, there was no relationship between angiogenic factors and placental lipid metabolism parameters. Free fatty acids were predictive of elevated sFlt-1 and sEng, while C-peptide was predictive of an elevated sFlt1/PlGF ratio. The findings in this study generate a model to predict elevated antiangiogenic factor values and the relationship between them with different products of lipid and carbohydrate metabolism in maternal serum and placenta in preeclampsia.

Indexed as

Pre-EclampsiaVascular Endothelial Growth Factor Receptor-1Angiogenesis Inducing AgentsC-PeptideEndoglinEnergy MetabolismFatty AcidsFemaleHumansLipidsPlacentaPlacenta Growth FactorPregnancyTriglyceridesAngiogenesis Inducing AgentsC-PeptideEndoglinFatty AcidsFLT1 protein, humanLipidsPlacenta Growth FactorTriglyceridesVascular Endothelial Growth Factor Receptor-1angiogenic markerscarbohydrate metabolismcorrelationesterificationgestational hypertensionlipid metabolismoxidationplacental functionplacental villous explantstriglyceride

Identifiers

PMID35631313
PMCPMC9145768
OpenAlexW4282938839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.